Other safety alerts
|
| |
| European Union: Precautionary measures to address potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines |
| |
| |
| |
|
| Related Information: | | European Union: PRAC assessing new data on potential risk of neurodevelopmental ... Posted 2025-07-12 | | Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronos... Posted 2025-06-11 | | The United Kingdom: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epil... Posted 2025-06-11 | | Australia: Potential risk of neurodevelopmental disorders in children born to me... Posted 2025-03-07 | | The United Kingdom: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epil... Posted 2025-02-14 | | The United Kingdom: Valproate use in men: as a precaution, men and their partner... Posted 2024-09-06 | | Singapore: Epilim® (valproate): Updates and new measures relating to the risk of... Posted 2024-01-24 | | European Union: Potential risk of neurodevelopmental disorders in children born ... Posted 2024-01-13 | | The United Kingdom: Valproate: re-analysis of study on risks in children of men ... Posted 2023-08-31 | | European Union: EMA review of data on paternal exposure to valproate Posted 2023-08-17 | | The United Kingdom: Safety of valproate – new study on risks in children of men ... Posted 2023-08-17 | | Singapore: Epilim® (valproate): Risk of neurodevelopmental disorders including a... Posted 2023-03-22 | | Epilim® (valproate) - Risk of neurodevelopmental disorders including autism spec... Posted 2023-03-22 | |
